Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
30 Outubro 2024 - 5:05PM
PR Newswire (US)
LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Aadi Bioscience,
Inc. (NASDAQ: AADI) today announced that it will report third
quarter 2024 financial results and provide recent corporate updates
on Wednesday, November 6, 2024. These results will be
available under the "Investors & News" page of the Aadi
Bioscience website at aadibio.com.
About Aadi Bioscience
Aadi is a precision oncology company focused on the
commercialization of FYARRO® for the treatment of adult
patients with locally advanced unresectable or metastatic malignant
perivascular epithelioid cell tumor (PEComa). More information on
the Company is available on the Aadi website at www.aadibio.com and
connect with us on Twitter and LinkedIn.
Contact:
IR@aadibio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-report-third-quarter-2024-results-and-corporate-update-302291958.html
SOURCE Aadi Bioscience
Copyright 2024 PR Newswire
Aadi Bioscience (NASDAQ:AADI)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Aadi Bioscience (NASDAQ:AADI)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
